← Leaderboards
Adrian Guthals
Mapp Biopharmaceutical, Inc.
$1,345,419
Attributed
$1,345,419
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $865.4K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,120,419 · 2
CDC$225,000 · 1
By mechanism
R44$865,373 · 1
R43$480,046 · 2
Top collaborators
No co-investigators on record.
Most similar at Mapp Biopharmaceutical, Inc.
Same institution · by research overlap
- Ronald T Aimes$3,000,000
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsAntibodiesTechnologyProteomicsCollectionResearch PersonnelInstrumentationSamplingCovid-19 PandemicComputer SoftwareCostCoronavirus DiseaseBehaviorBeta-AspartateCystineComplexCommunitiesComplex AnalysisBiological Response Modifier TherapyBiopharmaceutical IndustryBlindArthritisComputersBiological
Grant awards (4)
An adaptive compute solution for characterizing macromolecular complexes by mass spectrometry with electron-based fragmentation$1
R44 · FY2023 · GM · contact PI
An adaptive compute solution for characterizing macromolecular complexes by mass spectrometry with electron-based fragmentation$865,372
R44 · FY2022 · GM · contact PI
Direct sequencing of serum antibodies after infection$255,046
R43 · FY2017 · AI · contact PI
Direct Sequencing of Antibodies of the Influenza Immune Response$225,000
R43 · FY2017 · IP · contact PI